Skip to main content

Table 1 Demographic data of studied group (44 children)

From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool

 

Mean SD (min-max)

Age/years

9.8 ± 5.6 (2–18)

Weight (in kg)

38.1 ± 23 (8–80)

Height (in cm)

124.2 ± 37.4 (60–178)

BSA

1.12 ± 0.51 (0.42–1.98)

Sex

N

%

 Male

18

40.9

 Female

26

59.1

Family history

5

11.4

Consanguinity

5

11.4

Major adverse effects*

14

31.8

  1. *Major adverse effects include hospitalization for HF (five cases), death (five cases), arrhythmia (three cases), and brain infarction (1 case)